Entera Bio (ENTX) Treasury Shares (2024 - 2025)
Entera Bio (ENTX) recorded quarterly Treasury Shares of $142981.0 in Q4 2025, down 26.48% on a QoQ basis from $194472.0 in Q4 2024, and down 26.48% year-over-year from $194472.0 in Q4 2024.
Entera Bio (ENTX) Treasury Shares (2024 - 2025) Analysis & Trends
Entera Bio has disclosed Treasury Shares across 2 years of filings, most recently posting $142981.0 for Q4 2025.
- Quarterly Treasury Shares fell 26.48% year-over-year to $142981.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $142981.0 (down 26.48% YoY) and the FY2025 annual result came in at $142981.0, down 26.48% from the prior year.
- Treasury Shares eased to $142981.0 in Q4 2025, from $194472.0 in the prior quarter.
- Over five years, Treasury Shares peaked at $194472.0 in Q4 2024 and troughed at $142981.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Entera Bio | 56.59 Mn | 52.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 142,981.00 |
| Dec 31, 2025 | 142,981.00 |
| Dec 31, 2024 | 194,472.00 |
| Dec 31, 2024 | 194,472.00 |